Factorial Analysis of the Cardiometabolic Risk Influence on Redox Status Components in Adult Population

Table 3

The bivariate Spearman’s correlation analysis between tSHG, PAB, and PAB/tSHG index and clinical markers.

	tSHG, μmol/L	PAB, HKU	PAB/tSHG index
Age, years	-0.037	-0.215	-0.121
BMI, kg/m^2	0.092	-0.059	-0.093
WC, cm	0.183	-0.084	-0.164
WHtR	0.158	0.036	0.017
SBP, mmHg	-0.005	0.116	0.072
DBP, mmHg	0.004	0.035	0.016
Glucose, mmol/L	0.243	-0.192	-0.294
HbA1c, %	0.271	-0.138	-0.237
Total cholesterol, mmol/L	-0.029	0.160	0.114
HDL-c, mmol/L	-0.355	0.116	0.308
LDL-c, mmol/L	-0.061	0.178	0.146
TG, mmol/L	0.397	-0.096	-0.318
HsCRP, mg/L	0.033	0.154	0.067
GGT, U/L	0.258	-0.150	-0.265
Uric acid, μmol/L	0.171	-0.206	-0.258
VAI	0.391	-0.104	-0.334
LAP	0.347	-0.094	-0.320
tSHG, μmol/L	—	-0.114	-0.742
PAB, HKU	-0.114	—	0.701
siMS score	0.377	-0.111	-0.321

Data are presented as the correlation coefficient Rho (). , , .